Skip to content

Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study

Evaluating the Effectiveness of Axiostat Hemostatic Dressing Material Versus Conventional Method of Hemostasis and Healing of Extraction Wounds in Patients on Oral Anti-Platelet Drugs - A Comparative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03108365
Enrollment
40
Registered
2017-04-11
Start date
2014-12-19
Completion date
2016-03-24
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Extraction

Brief summary

The rationale of this study was to evaluate the efficacy of Axiostat hemostatic dental dressing in achieving hemostasis post-extraction and determining its effect on pain and healing of the extraction wound, compared to control, i.e. conventional method of extraction in patients on oral anti-platelet therapy.

Interventions

DEVICEAxiostat

Axiostat® is a sterile, non-absorbable haemostatic dressing intended to control profuse bleeding within minutes of application by providing an active mechanical barrier to the wound site. Axiostat® stops moderate to severe bleeding due to cuts, abrasions, lacerations, venous/arterial punctures and more. Mechanism of action is such that Axiostat® is an extremely positive dressing that becomes very sticky in the presence of negatively charged blood and thus seals the wound area.

Size: 1 x 1 cm

Sponsors

Axio Biosolutions Pvt. Ltd.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing multiple tooth extractions aged b/w 35- 70 years and with INR values ≤ 3.5 (1-3.5) * If present, sugar level should be under control

Exclusion criteria

* Patients undergoing a single tooth or multiple extractions in same quadrant; and those with an allergy to seafood.

Design outcomes

Primary

MeasureTime frameDescription
Time to achieve haemostasis1 DayTime to achieve hemostasis by observing the time at which blood oozing through or from periphery of the dressing stops.

Secondary

MeasureTime frameDescription
Pain & Healing ScaleUpto 1 DayPatients comfort level as assessed by verbal inquiry after completion of procedure.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026